Pharmaceutical Patent Licensing

2024 FDA Exclusivity Strategies, Biopharma Patent Valuation Methods & Royalty Rate Benchmarking: Expert Guide for Industry Professionals

2024 Biopharma Expert Guide: Master FDA exclusivity strategies, premium patent valuation methods, and royalty rate benchmarking to maximize market protection before 2024 regulatory deadlines. Backed by FDA 2024 Draft Guidance…

River Kingston December 18, 2025

Pharmaceutical Patent Licensing

COVID-19 Therapy Licensing: A Comprehensive Guide to Compulsory Licensing in Emerging Markets, Pharma Patent Pool Agreements & Access Strategies

Navigating COVID-19 therapy licensing in emerging markets demands urgent, WTO-compliant strategies—67% of low-income countries faced critical shortages due to restrictive terms (WHO 2023). Compare Patent Pools vs. Bilateral Licensing: MPP-endorsed…

River Kingston December 12, 2025

Pharmaceutical Patent Licensing

Strategic Guide to FDA Orange Book Listings, Biosimilar Patent Settlement Deals & Oncology Biologics Patent Landscape Analysis

With only 60% of approved oncology biosimilars reaching the U.S. market, mastering FDA Orange Book listings, biosimilar patent settlements, and patent landscape analysis is critical for accessing the $200 billion…

River Kingston November 23, 2025

Pharmaceutical Patent Licensing

Biologic Patent Litigation Trends, Clinical Trial Data Exclusivity & Orphan Drug Patent Licensing: 2024 Expert Guide to Regulations, Strategies & Risks

2024’s biologic patent litigation surge (up 42% in 5 years) demands expert navigation of clinical trial data exclusivity and orphan drug licensing—critical for US biotech firms. According to FDA’s 2024…

River Kingston October 30, 2025

Pharmaceutical Patent Licensing

The Definitive Guide to AI Drug Discovery & CRISPR Therapeutics Licensing: Patent Term Extension Strategies for Biotech Innovators

AI-driven drug discovery cuts preclinical costs by $40M per candidate, but 78% of biotechs face licensing roadblocks (McKinsey 2023). This guide simplifies AI drug discovery patent licensing, CRISPR therapeutics models,…

River Kingston October 21, 2025